POSSIBLE OTRIVINE-INDUCED BRUTAL BILATERAL EXSUDATIVE RETINAL DETACHMENT
Retinal detachment (RD) is the separation of the neurosensory retina (NSR) from the underlying retinal pigment epithelium (RPE). The purpose is to report a case of patiente presenting a brutal bilateral exsudative retinal detachment. A 25-year-old woman with no significant ocular history noted rapid, painless blurring in both eyes, facial edema and buccal dryness 2 days following a nasal spray of Otrivine by selfmedication for nasal stuffiness . Her best-corrected visual acuity was hand movement perception in both eyes. The anterior chamber, iris, and intraocular pressures were within normal limits. Dilated fundus examination showed clear vitreous with intraretinal hard exsudats mimicking an hypertensive retinopathy and inferior retinal detachment in both eyes. We suspected a drug-induced retinal detachment. We ask several experts for their opinion toward this case. Physicians should enquire about the overuse of nasal sprays.They must monitor patients' use of nasal sprays containing oxymetazoline and advise those with chronic nasal congestion that the overuse of this drug may be dangerous.
2. Kang HK, Luff AJ; Management of retinal detachment: a guide for non-ophthalmologists. BMJ. 2008 May 31;336(7655):1235-40.
3. Gariano RF, Chane-Hee K; Evaluation and Management of Suspected Retinal Detachment. Am Fam Physician. 2004 Apr 1;69(7):1691-9.
4. Trigui A, Khadi N, Ghorbel I, Fekik J. Les décollements de rétine bilateraux. J.I.M.Sfax.2005 ;1(10) :23-6. Disponible sur: http://www.medecinesfax.org˃article06-9-10.pdf.
5. Zinn, K , Greenseid, D. Toxicology of the retinal pigment epithelium. Int Ophthalmol Clin 1975 ; 15, 147–58.
6. Stephen H. Tsang and Tarun Sharma. Drug-Induced Retinal Toxicity . AEMB, volume 1085 ;Atlas of Inherited Retinal Diseases ; Chapter 48.
7. Schwartz SG, Grysbowski A, Wasinska-Borowiec W, Flynn HW, Mieler WF. Update on pharmacologic retinal vascular toxicity. Curr Pharm Des 2015;21:4694–7.
8. Meier-R, Meier-Ruge. Morphology of experimental chloroquine retinopathy in the rabbit. Ophthalmologica 1973 ; 150: 127–37.
9. Otrivine. Active substance(s): Xylometazoline Hydrochloride available online https://www.drugs.com/uk/otrivine-adult-nasal-spray-leaflet.html
10. Morris S, Eccles R, Martez SJ, et al. An evaluation of nasal response following different treatment regimens of oxymetazoline with reference to rebound congestion.Am J Rhinol 1997;11:109–15.
11. Recep D, Hasan G, Mustafa S, Fatih S, Zeynel Abidin T et al. Systemic side effects of locally used oxymetazoline . Int J Clin Exp Med 2015;8(2):2674-8
12. Loewen AH, Hudon ME and Hill MD. Thunderclap headache and reversible segmental cerebral vasoconstriction associated with use of oxymetazoline nasal spray. CMAJ 2004; 171: 593-94.
13. Ayse Ipek Akyuz Unsal1, Yesim Basal2, Serap Birincioglu3, Tolga Kocaturk1, Harun Cakmak1, Alparslan Unsal4, Gizem Cakiroz5, Nüket Eliyatkın6, Ozden Yukselen7, Buket Demirci5.Ophthalmic adverse effects of nasal decongestants on an experimental rat model. Arq Bras Oftalmol. 2018;81(1):53-8.
14. Mondal L, Basu S, Baıdya K, Bhaduri G. Central serous chorioretinopathy after dacryocystorhinostomy operation on the same side.Indian J Ophthalmol. 2009;57(1):57-8.
15. Buysschaert I, Van DJ, Dujardin K. Hypertensive crisis and end-organ damage induced by over-the-counter nasal decongestant abuse. Eur Heart J. 2011;32(24):3114.
16. Hafidi Z, Handor H , Oudanane S ,Laghmari M, Derrar R , Sabrane I et al.Décollement exsudatif bilatéralde la rétine révélant une toxémie gravidique. J fr ophtalmol (2014) ; 37 :65-6
17. Soderman P: Nose drops can induce cerebral reactions in children.Latartidmingen 1983; 80: 3286-7.
18. Blackwood GW: Severe psychological disturbance resulting from abuse of nasal decongestants. Scott Med J 1982; 27: 175-6.
19. Cem Ozturkmen, Mustafa Berhuni, Pediatric Case with acute bilateral serous macular detachment. Korean J Ophthalmol 2019;33(2):196-197 https://doi.org/10.3341/kjo.2018.0067 .
20. Ovet G, Alpfidan I, Sakarya Y, et al. The acute effect of pseudoephedrine on choroidal thickness. Clin Ter 2016;167:63-6.
21. Michael JC, Pak J, Pulido J, de Venecia G. Central serous chorioretinopathy associated with administration of sympathomimetic agents. Am J Ophthalmol 2003;136:182-5.
22. Loo JL, Lee SY, Ang CL. Can long-term corticosteriods lead to blindness? A case series of central serous chorioretinopathy induced by corticosteroids. Ann Acad Med Singapore. 2006; 35(7):496–9.
23. Scroggs, MW, Klintworth, GK . Drugs and toxins. In: Pathobiology of Ocular Disease. New York, 1994 pp. 1163–88.
24. LARS M , ULRICH S. An Overview on the Toxic Morphological Changes in the Retinal Pigment Epithelium after Systemic Compound Administration. Toxicologic Pathology 2007 ; 35:252–267, 2007.DOI: 10.1080/01926230601178199
25. Junping L, Ramesh C. Tripathi3 and Brenda J. Tripathi3,4 Drug-Induced Ocular Disorders. Drug Safety 2008; 31 (2): 127-41.
26. Faure, I. Audo, Iatrogénie oculaire des médicaments systémiquesC. EMC. 2016.
27. Jessica L Morris. Assessment of Maternal and Child Health in Fort Dauphin, Madagascar. SEED Madagascar. Novembre 2011 Novembre 2012.
28. Banque mondiale. Les indicateurs du développement dans le monde.Disponible en ligne sur https://databank.banquemondiale.org/source/world-development-indicators
29. Mary Danielli (1947) . The Witches of Madagascar: A Theory of the Function of Witches and of their Organization Based on Observations of an Existing Cult, Folklore, 1947 ; 58(2) : 261-76, DOI: 10.1080/0015587X.1947.9717852
Copyright (c) 2019 Advances in Social Sciences Research Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
All authors of manuscripts accepted for publication in the journal Transactions on Networks and Communications are required to license the Scholar Publishing to publish the manuscript. Each author should sign one of the following forms, as appropriate:
License to publish; to be used by most authors. This grants the publisher a license of copyright. Download forms (MS Word formats) - (doc)
Publication agreement — Crown copyright; to be used by authors who are public servants in a Commonwealth country, such as Canada, U.K., Australia. Download forms (Adobe or MS Word formats) - (doc)
License to publish — U.S. official; to be used by authors who are officials of the U.S. government. Download forms (Adobe or MS Word formats) – (doc)
The preferred method to submit a completed, signed copyright form is to upload it within the task assigned to you in the Manuscript submission system, after the submission of your manuscript. Alternatively, you can submit it by email firstname.lastname@example.org